Circadian Rhythms, Cancers and Chronotherapy (2nd Edition)
A Special Issue of Cancers (ISSN 2072-6694) belonging to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (30 June 2026) | Viewed by 1246
Editors
Interests: circadian clocks; biological rhythms; chronopharmacology; chronotherapy
Special Issues, Collections and Topics in MDPI journals
2. Cancer Research Centre, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK
3 UPR “Chronotherapy, Cancers and Transplantation”, Faculty of Medicine, Paris-Saclay University, 94800 Villejuif, France
Interests: cancer chronotherapeutics; circadian rhythms; supportive care; digital health
Special Issues, Collections and Topics in MDPI journals
Interests: sleep disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is the second edition of a previous Special Issue on the topic of “Circadian rhythms, Cancers and Chronotherapy” (https://www.mdpi.com/journal/cancers/special_issues/2NS03XTM5G) This Special Issue aims to advance precision and personalized cancer medicine. Taking into consideration this goal, we invite you to submit original or review scientific or biomedical articles on these topics. We welcome original contributions reporting new challenging scientific results and/or highlighting novel approaches regarding the molecular, cellular, and physiologic interactions between circadian rhythms and cancer processes and treatments, as well as their healthcare implications. Indeed, a hierarchical network of cellular clocks, consisting of a system of 15 clock genes, orchestrates cellular metabolism, proliferation, and survival, as well as physiology and responses to therapeutic agents, over a 24 h timescale. Accumulating evidence supports an important role of circadian rhythms both for carcinogenesis processes from initiation to progression and metastasis, and for the tolerability and efficacy of all kinds of cancer treatments. However, circadian rhythms can differ as a function of sex, age, environment, genetics, or other biological factors in experimental cancer models, among people at risk of cancer, and among cancer patients. Manuscripts on the relevance of circadian or other biological clocks in the following research areas may include (but are not limited to) the following topics:
- In vitro and in vivo experimental cancer models;
- Drug development and chronotherapy;
- Chemotherapy, immunotherapy, targeted agents, radiotherapy, surgery;
- Circadian host or tumor biomarkers;
- Electronic patient-reported outcomes;
- Circadian rhythms and sleep;
- Sex- and age specificities;
- Clinical trial designs;
- Mathematical models and artificial intelligence;
- Digital healthcare, telemedicine and logistics.
We look forward to receiving your contributions.
Prof. Dr. Francis Levi
Dr. Pasquale F. Innominato
Dr. Esra Tasali
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug development and chronotherapy
- chemotherapy, immunotherapy, targeted agents, radiotherapy, surgery
- circadian host or tumor biomarkers
- electronic patient-reported outcomes
- circadian rhythms and sleep
- sex- and age specificities
- clinical trial designs
- mathematical models and artificial intelligence
- digital healthcare, telemedicine and logistics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
